1. Home/
  2. Compounds/
  3. doxorubicin:navitoclax (2:1 mol/mol)

doxorubicin:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2doxorubicin:navitoclax (2:1 mol/mol)
PharmacoGx doxorubicin:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to doxorubicin:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA ADAT2 CTRPv2 pan-cancer AAC 0.16 4e-05
mRNA GIPC1 CTRPv2 pan-cancer AAC -0.16 4e-05
mRNA LINC00684 CTRPv2 pan-cancer AAC 0.14 4e-05
mRNA GPR143 CTRPv2 pan-cancer AAC -0.14 4e-05
mRNA MYB CTRPv2 pan-cancer AAC 0.17 4e-05
mRNA BCL2L2-PABPN1 CTRPv2 pan-cancer AAC 0.14 4e-05
mRNA AHCTF1 CTRPv2 pan-cancer AAC 0.14 4e-05
mRNA ANKRD17 CTRPv2 pan-cancer AAC 0.14 4e-05
mRNA NEDD4 CTRPv2 pan-cancer AAC -0.14 4e-05
mRNA EIF4EBP2 CTRPv2 pan-cancer AAC 0.14 4e-05
Download CSV